🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Owing to that the previous study of the investigators showed that SBRT plus...
Status
Unknown
Location
Changhai Hospital affiliated to Naval Medical University
Start Date
2023-06-25
Trial ID
NCT05783076
Treatments Being Tested
This study was a single-arm, open-label, "3 + 3" dose-escalation Explorator...
Status
Recruiting
Location
Fudan University
Start Date
2022-12-28
Trial ID
NCT05587543
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of escal...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2021-05-10
Trial ID
NCT04762225
Treatments Being Tested
Older age is an independent poor outcome predictor among COVID-19 hospitali...
Status
Completed
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2020-05-27
Trial ID
NCT04374526
Treatments Being Tested
This is a Phase II trial to study the effectiveness and security of cisplat...
Status
Unknown
Location
Haiqiang Mai
Start Date
2015-03
Trial ID
NCT02421640
Treatments Being Tested
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-11-10
Trial ID
NCT01218867
Treatments Being Tested
DELTA-1 is a phase 2 clinical trial to evaluate the efficacy and safety of ...
Status
Terminated
Location
University of California San Diego, Moores Cancer Center
Start Date
2021-10-07
Trial ID
NCT05050006
Treatments Being Tested
This study is a randomized controlled trial among 120 recently displaced wo...
Status
Completed
Location
Alliance for Public Health
Start Date
2025-03-27
Trial ID
NCT06679114
Treatments Being Tested
This study is an investigator-initiated, open-label Phase I clinical trial ...
Status
Recruiting
Location
the Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-09-26
Trial ID
NCT07193628
Treatments Being Tested
RATIONALE: Aldesleukin may stimulate lymphocytes to kill melanoma cells. Tr...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2010-04
Trial ID
NCT01106235
Treatments Being Tested